首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17)
【24h】

Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17)

机译:通过靶向明胶酶B /基质金属蛋白酶9(MMP-9)和TNF-α转化酶(TACE / ADAM-17),从合成肽库中定义肽抑制剂

获取原文
           

摘要

Gelatinase B/matrix metalloproteinase-9 (MMP-9) is a regulatory and effector metalloproteinase in inflammation. TNF-α is an important proinflammatory cytokine and is released by the action of a Zn2+-containing converting enzyme (TACE/ADAM-17). Both metallo-enzymes play important roles during the development of shock syndromes. Combinatorial chemical synthesis and subsequent library deconvolution were previously used to define a peptide inhibitor (Regasepin1) acting, almost to the same degree, on neutrophil collagenase/MMP-8 and MMP-9 in vitro, and protecting mice against lethal endotoxinemia in vivo. We have now extended this approach by incorporating D-form amino acids and residues preferred by TACE. A new peptide library was designed and synthesized, and by deconvolution new peptide inhibitors were defined. These included a TACE-specific inhibitor, an MMP-9- specific inhibitor, and inhibitors for both enzymes.
机译:明胶酶B /基质金属蛋白酶9(MMP-9)是炎症中的一种调节性和效应性金属蛋白酶。 TNF-α是一种重要的促炎细胞因子,是通过含Zn 2 + 的转化酶(TACE / ADAM-17)释放的。两种金属酶在休克综合症的发展过程中都起着重要的作用。以前使用组合化学合成法和随后的文库去卷积法来定义一种肽抑制剂(Regasepin1),其在体外几乎以相同的程度作用于嗜中性粒细胞胶原酶/ MMP-8和MMP-9,并在体内保护小鼠免受致死性内毒素血症的侵害。现在,我们通过结合D型氨基酸和TACE首选的残基扩展了这种方法。设计并合成了新的肽库,并通过反卷积定义了新的肽抑制剂。这些包括TACE特异性抑制剂,MMP-9特异性抑制剂和两种酶的抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号